- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05287074
The Significance of a Timely Food Allergy Diagnosis and Optimal Surveillance of Nutritional Status in Children
March 9, 2022 updated by: Vilnius University
The aim of this study is to gain more knowledge on the nutritional and immunological aspects of allergy to milk and eggs in children.
Study Overview
Status
Enrolling by invitation
Conditions
Detailed Description
Food allergy in children is an emerging problem in many countries.
Milk and eggs are important sources of nutrition in childhood.
Restricting these products in children's diets can affect the quality of child's life and nutrition, which is paramount to good physical and mental child development during this vulnerable period of life.
The aim of this study is to gain more knowledge on the nutritional and immunological aspects of immunoglobulin E (IgE) mediated allergy to milk and eggs in children.
In this study we will analyze parent perceived child's quality of life, factual nutrition (assessed by 3-day food diaries), food allergy self efficacy measure for parents, parent perceived quality of life will be assessed using Food Allergy Quality of Life Questionnaire - Parent Form, anthropometric measures of children (height and weight), serum nutritional markers (vitamin D, calcium, magnesium, iron and phosphorous), sensitization tests (specific Immunoglobulin E (sIgE) to milk and egg and their components) as well as markers of allergic inflammation (interleukin 10, 13, 17, 25 and 33, eosinophil count and serum Immunoglobulin E).
Food allergy will be confirmed by an oral food challenge (OFC), variables will be compared between different OFC outcomes (sensitized-allergic/sensitized-non-allergic).
Study Type
Observational
Enrollment (Anticipated)
200
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Vilnius, Lithuania
- Vilnius University Hospital Santaros Clinics
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
6 months to 12 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Subjects from 6 months to 12 years of age with suspected or confirmed allergy to chicken's egg and/or cow's milk, referred for an oral food challenge with milk or egg will be enrolled.
Description
Inclusion Criteria:
- Subjects from 6 months to 12 years of age and their parents / guardians.
- Subjects with suspected or confirmed allergy to chicken's egg and/or cow's milk. Suspected food allergy is defined as sensitization to a food that has not been consumed recently (in the last 3 months) without symptoms or sensitization to a food that has never been consumed. A confirmed food allergy is defined as a food allergy that has previously been confirmed by a positive result of an oral food challenge.
- Legal guardians of the subject are capable to sign a written informed consent form.
Exclusion Criteria:
- Subjects to whom food allergies are unlikely (who have recently eaten a suspected food without symptoms or who have not eaten food recently but have never had symptoms and are not sensitized).
- Subjects to whom an oral food challenge is contraindicated.
- Subjects with comorbid chronic diseases affecting the child 's nutrition and growth.
- Legal guardians of the subject do not wish to participate in the study or are unable to sign a written consent form.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Evaluation of the daily food intake of children following egg and/or milk elimination diets.
Time Frame: Within one month of enrolment.
|
Dietary intake will be assessed by a 3-day food diary, the nutrient intake will be analyzed using national food composition database and a nutritional analysis software.
|
Within one month of enrolment.
|
|
Antropometric measurements - Z-scores
Time Frame: Within one day of enrolment.
|
Anthropometric measurements (weight and height) will be recorded and evaluated as Z-scores using the WHO ANTHRO program and WHO ANTHRO Plus Software.
|
Within one day of enrolment.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Evaluation of parental confidence in managing food allergy.
Time Frame: Within one month of enrollment
|
Parental confidence will be assessed using Food Allergy Self-Efficacy Scale for Parents (FASE-P), (scale of 0 to 100).
|
Within one month of enrollment
|
|
Evaluation of the parent perceived quality of life of children following egg and/or milk elimination diets.
Time Frame: Within one month of enrollment
|
Parent perceived quality of life will be assessed using Food Allergy Quality of Life Questionnaire - Parent Form (FAQLQ-PF), (scale of 0 to 6).
|
Within one month of enrollment
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Prick to Prick test with cow's milk mean value.
Time Frame: Within one month of enrollment
|
Prick to Prick test with cow's milk mean value.
|
Within one month of enrollment
|
|
Prick to Prick test with hen's egg mean value.
Time Frame: Within one month of enrollment
|
Prick to Prick test with hen's egg mean value.
|
Within one month of enrollment
|
|
Measurement of serum total IgE.
Time Frame: Within one month of enrollment
|
Measurement of serum total IgE.
|
Within one month of enrollment
|
|
Measurement of serum eosinophils.
Time Frame: Within one month of enrollment
|
Measurement of serum eosinophils
|
Within one month of enrollment
|
|
Measurement of serum specific IgE to milk extract.
Time Frame: Within one month of enrollment
|
Measurement of serum specific IgE to milk extract.
|
Within one month of enrollment
|
|
Measurement of serum specific IgE to egg extract.
Time Frame: Within one month of enrollment
|
Measurement of serum specific IgE to egg extract.
|
Within one month of enrollment
|
|
Measurement of serum specific IgE to casein.
Time Frame: Within one month of enrollment
|
Measurement of serum specific IgE to casein.
|
Within one month of enrollment
|
|
Measurement of serum specific IgE to betalactoglobulin.
Time Frame: Within one month of enrollment
|
Measurement of serum specific IgE to betalactoglobulin.
|
Within one month of enrollment
|
|
Measurement of serum specific IgE to ovomucoid.
Time Frame: Within one month of enrollment
|
Measurement of serum specific IgE to ovomucoid.
|
Within one month of enrollment
|
|
Measurement of serum specific IgE to ovalbumin.
Time Frame: Within one month of enrollment
|
Measurement of serum specific IgE to ovalbumin.
|
Within one month of enrollment
|
|
Laboratory measurement of vitamin D concentration.
Time Frame: Within one month of enrollment
|
Laboratory measurement of vitamin D concentration.
|
Within one month of enrollment
|
|
Laboratory measurement of serum calcium concentration.
Time Frame: Within one month of enrollment
|
Laboratory measurement of serum calcium concentration.
|
Within one month of enrollment
|
|
Laboratory measurement of serum phosphorus concentration.
Time Frame: Within one month of enrollment
|
Laboratory measurement of serum phosphorus concentration.
|
Within one month of enrollment
|
|
Laboratory measurement of serum iron concentration.
Time Frame: Within one month of enrollment
|
Laboratory measurement of serum iron concentration.
|
Within one month of enrollment
|
|
Laboratory measurement of serum magnesium concentration.
Time Frame: Within one month of enrollment
|
Laboratory measurement of serum magnesium concentration.
|
Within one month of enrollment
|
|
Laboratory measurement of serum interleukin 25.
Time Frame: Within one month of enrollment
|
Laboratory measurement of serum interleukin 25.
|
Within one month of enrollment
|
|
Laboratory measurement of serum interleukin 33.
Time Frame: Within one month of enrollment
|
Laboratory measurement of serum interleukin 33.
|
Within one month of enrollment
|
|
Laboratory measurement of serum interleukin 17.
Time Frame: Within one month of enrollment
|
Laboratory measurement of serum interleukin 17.
|
Within one month of enrollment
|
|
Laboratory measurement of serum interleukin 13.
Time Frame: Within one month of enrollment
|
Laboratory measurement of serum interleukin 13.
|
Within one month of enrollment
|
|
Laboratory measurement of serum interleukin 10.
Time Frame: Within one month of enrollment
|
Laboratory measurement of serum interleukin 10.
|
Within one month of enrollment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Ieva Adomaite, MD, Vilnius University Faculty of Medicine
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 1, 2021
Primary Completion (Anticipated)
July 1, 2023
Study Completion (Anticipated)
June 1, 2028
Study Registration Dates
First Submitted
July 14, 2021
First Submitted That Met QC Criteria
March 9, 2022
First Posted (Actual)
March 18, 2022
Study Record Updates
Last Update Posted (Actual)
March 18, 2022
Last Update Submitted That Met QC Criteria
March 9, 2022
Last Verified
July 1, 2021
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- MAMS2018
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Food Allergy in Children
-
Vilnius UniversityEnrolling by invitationFood Allergy in Children | Food Allergy in InfantsLithuania
-
Chinese University of Hong KongRecruitingFood Allergy | Food Allergy in ChildrenHong Kong
-
Children's National Research InstituteNational Institute of Allergy and Infectious Diseases (NIAID); Northwestern... and other collaboratorsRecruiting
-
Federico II UniversityCompleted
-
Rhode Island HospitalVirtually Better, Inc.CompletedFood Allergy in Children
-
National Jewish HealthRoche-GenentechRecruitingFood Allergy | Food Allergy in ChildrenUnited States
-
Stanford UniversityTerminatedFood Allergy | Food Allergy in ChildrenUnited States
-
Rhode Island HospitalCompletedFood Allergy in Children